Cargando…

Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents

Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetable. Functional ingredients of M. charantia play important roles in body health and human nutrition, which can be used directly or indirectly in treating or preventing hypergly...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bilin, Li, Zhiliang, Zeng, Ting, Zhan, Jianfeng, Wang, Shuzhen, Ho, Chi-Tang, Li, Shiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000558/
https://www.ncbi.nlm.nih.gov/pubmed/35408574
http://dx.doi.org/10.3390/molecules27072175
_version_ 1784685463740612608
author Xu, Bilin
Li, Zhiliang
Zeng, Ting
Zhan, Jianfeng
Wang, Shuzhen
Ho, Chi-Tang
Li, Shiming
author_facet Xu, Bilin
Li, Zhiliang
Zeng, Ting
Zhan, Jianfeng
Wang, Shuzhen
Ho, Chi-Tang
Li, Shiming
author_sort Xu, Bilin
collection PubMed
description Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetable. Functional ingredients of M. charantia play important roles in body health and human nutrition, which can be used directly or indirectly in treating or preventing hyperglycemia-related chronic diseases in humans. The hypoglycemic effects of M. charantia have been known for years. In this paper, the research progress of M. charantia phytobioactives and their hypoglycemic effects and related mechanisms, especially relating to diabetes mellitus, has been reviewed. Moreover, the clinical application of M. charantia in treating diabetes mellitus is also discussed, hoping to broaden the application of M. charantia as functional food.
format Online
Article
Text
id pubmed-9000558
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90005582022-04-12 Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents Xu, Bilin Li, Zhiliang Zeng, Ting Zhan, Jianfeng Wang, Shuzhen Ho, Chi-Tang Li, Shiming Molecules Review Momordica charantia L., a member of the Curcubitaceae family, has traditionally been used as herbal medicine and as a vegetable. Functional ingredients of M. charantia play important roles in body health and human nutrition, which can be used directly or indirectly in treating or preventing hyperglycemia-related chronic diseases in humans. The hypoglycemic effects of M. charantia have been known for years. In this paper, the research progress of M. charantia phytobioactives and their hypoglycemic effects and related mechanisms, especially relating to diabetes mellitus, has been reviewed. Moreover, the clinical application of M. charantia in treating diabetes mellitus is also discussed, hoping to broaden the application of M. charantia as functional food. MDPI 2022-03-28 /pmc/articles/PMC9000558/ /pubmed/35408574 http://dx.doi.org/10.3390/molecules27072175 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Xu, Bilin
Li, Zhiliang
Zeng, Ting
Zhan, Jianfeng
Wang, Shuzhen
Ho, Chi-Tang
Li, Shiming
Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
title Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
title_full Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
title_fullStr Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
title_full_unstemmed Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
title_short Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
title_sort bioactives of momordica charantia as potential anti-diabetic/hypoglycemic agents
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000558/
https://www.ncbi.nlm.nih.gov/pubmed/35408574
http://dx.doi.org/10.3390/molecules27072175
work_keys_str_mv AT xubilin bioactivesofmomordicacharantiaaspotentialantidiabetichypoglycemicagents
AT lizhiliang bioactivesofmomordicacharantiaaspotentialantidiabetichypoglycemicagents
AT zengting bioactivesofmomordicacharantiaaspotentialantidiabetichypoglycemicagents
AT zhanjianfeng bioactivesofmomordicacharantiaaspotentialantidiabetichypoglycemicagents
AT wangshuzhen bioactivesofmomordicacharantiaaspotentialantidiabetichypoglycemicagents
AT hochitang bioactivesofmomordicacharantiaaspotentialantidiabetichypoglycemicagents
AT lishiming bioactivesofmomordicacharantiaaspotentialantidiabetichypoglycemicagents